Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
CITIUS ONCOLOGY, INC. market cap for the quarter ending 2026-06-30 was $68.74M, a 78.21% decline year-over-year.
CITIUS ONCOLOGY, INC. market cap for the quarter ending 2026-03-31 was $57.62M, a 13.41% decline year-over-year.
CITIUS ONCOLOGY, INC. market cap for the quarter ending 2025-12-31 was $83.02M, a 0.89% increase year-over-year.
CITIUS ONCOLOGY, INC. market cap for the quarter ending 2025-12-23 was $107.69M, a 50.51% increase year-over-year.
CITIUS ONCOLOGY, INC. market cap for fiscal 2026 was $68.74M.
CITIUS ONCOLOGY, INC. market cap for fiscal 2025 was $83.02M, a 0.89% increase from fiscal 2024.
CITIUS ONCOLOGY, INC. market cap for fiscal 2024 was $82.29M, a 221.29% increase from fiscal 2023.
CITIUS ONCOLOGY, INC. market cap for fiscal 2023 was $25.61M, a 4.33% increase from fiscal 2022.